Lv51
974 积分 2022-09-21 加入
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model-Based Assessments
2天前
已完结
CT-219 Clinical Evaluation of Fast-in-Time (FIT) Anti-CD19 CAR T—a Non-Viral, 2-Day Rapid Manufacture CAR T-Cell Therapy for B-Cell Malignancies
21天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
26天前
已完结
Multi-functional lipid nanoformulations for enhancing the efficacy of mRNA tumor vaccines by reversing tumor immunosuppressive microenvironment
26天前
已完结
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
26天前
已完结
A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges
26天前
已完结
CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
27天前
已完结
Potentiating CAR-T-cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal
1个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
皖公网安备34019202002308
